Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) and ZyVersa Therapeutics (NASDAQ:ZVSA – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability and dividends. Insider & Institutional Ownership 66.0% of Arrowhead Pharmaceuticals […]